CPDR is a program of the Uniformed Services University of the Health Sciences
and the Henry M. Jackson Foundation for the Advancement of Military Medicine

< Publications Archive

> 2002 Publications

1-10   11-20

 

21. Increasing the number of core samples taken at prostate needle biopsy enhances the detection of clinically significant prostate cancer.
Taylor JA, Gancarczyk KJ, Fant GV, McLeod DG.
Urology, 60(5):841-5, 2002.

 

22. Effect of race on biochemical disease-free outcome in patients with prostate cancer treated with definitive radiation therapy in an equal access health care system: radiation oncology report of the Department of Defense Center for Prostate Disease Research.
Johnstone PA, Kane CJ, Sun L, Wu H, Moul JW, McLeod DG, Martin DD, Kusuda L, Lance R, Douglas R, Donahue T, Beat MG, Foley J, Baldwin D, Soderdahl D, Do J, Amling CL.
Radiology, 225:420-6, 2002.

 

23. Radical prostatectomy versus radiation therapy for clinically localized prostate carcinoma: the butcher and the baker selling their wares.
Moul JW:
Cancer, 95:211-4, 2002.

 

24. Initiation of salvage therapy for prostate cancer.
Johnstone PA, Booth R, Riffenburgh RH, Amling CL, Kane CJ, Moul JW:
Prostate Cancer Prostatic Dis, 5:136-43, 2002.

 

25. Adenocarcinoma of the prostate: an expensive way to die.
Piper NY, Kusada L, Lance R, Foley J, Moul J, Seay T:
Prostate Cancer Prostatic Dis, 5:164-6, 2002.

 

26. Emerging role of adjuvant hormonal therapy.
McLeod DG.
Urology, 60(3 Suppl 1):13-20, 2002.

 

27. Overview consensus statement. Newer Approaches to androgen deprivation therapy in prostate cancer. The 2nd International Conference on Newer Approaches to Androgen Deprivation Therapy (ADT) in Prostate Cancer.
Carroll PR, Kantoff PW, Balk SP, Brown MA D’amico AV, George DJ, Grossfeld GD, Johnson CS, Kelly WK, Klotz L, Lee WR, Lubeck DP, McLeod DG, Oh WK, Pollack A, Sartor O, Smith MR, Hart C.
Urology, 60(3 Suppl 1):1-6, 2002.

 

28. Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program.
See WA, Wirth MP, McLeod DG, et al.,
J Urol. 168:429-35, 2002.

 

29. Epidemiology of radical prostatectomy for localized prostate cancer in the era of prostate specific antigen: an overview of the Department of Defense Center for Prostate Disease Research national database.
Moul JW, Wu H, Sun L, McLeod DG, Amling C, Lance R, Kusuda L, Donahue T, Foley J, Chung A, Sexton W, Soderdahl D and Rich NM.
Surgery, 132:213-9, 2002.

 

30. Diagnostic accuracy of prostate needle biopsy.
Donahue T, Moul J:
Curr Urol Rep, 3:215-21, 2002.

 

31. Molecular Dissection of the Prostate Cancer Genome.
Srikantan, V, and Srivastava S: R. Hoffman and A Heidenreich,
eds. In Prostate Cancer, Diagnosis and Surgical Treatment, Springer-Verlag, 25-40. 2002.